Literature DB >> 23754205

Clinical evaluation of sustained-release metronidazole gel versus metronidazole solution as an intracanal medicament in abscessed primary molars.

M B Bhangdia1, B Nandlal, G S Vijaykumar, P K Kulkarni, R Shanbhog.   

Abstract

AIM: To evaluate the efficacy of metronidazole gel versus metronidazole solution against Enterococcus faecalis in abscessed primary molars. STUDY
DESIGN: A clinical trial.
METHOD: Twenty pulpally involved non-vital carious human primary mandibular second molars with furcal abscess were randomly allocated into two groups to evaluate the efficacy of metronidazole gel (3% w/v) and metronidazole solution (0.5% w/v) against E. faecalis. Subjects in the first experimental group were subjected to treatment with metronidazole gel (3% w/v) and subjects in the second experimental group were treated with metronidazole solution (0.5% w/v). Two microbial samples (pre-operative and post-operative samples) were obtained from the root canals of each subject from both the groups; sub cultured and efficacy of both the groups were evaluated.
RESULTS: Overall percentage reduction of the mean colony forming unit (CFU) count of metronidazole gel (3% w/v) group was 96.39% and metronidazole solution (0.5 % w/v) was 90.90%. Results of intergroup t test of the percentage difference of mean CFU counts between both the groups revealed a statistically highly significant difference, i.e. p value--0.008 (p < 0.01).
CONCLUSIONS: Metronidazole gel (3% w/v) was more effective than metronidazole solution (0.5% w/v) against E. faecalis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754205     DOI: 10.1007/s40368-013-0047-2

Source DB:  PubMed          Journal:  Eur Arch Paediatr Dent        ISSN: 1818-6300


  16 in total

1.  [The preparation and in vitro release test of sustained release delivery gutta-percha point containing metronidazole].

Authors:  Jing Gao; Zhu-ping Wang; Xiao-guang Li; Duo Wang; Li Zhang
Journal:  Shanghai Kou Qiang Yi Xue       Date:  2004-12

2.  Variations in the susceptibilities of components of the endodontic microflora to biomechanical procedures.

Authors:  B P Gomes; J D Lilley; D B Drucker
Journal:  Int Endod J       Date:  1996-07       Impact factor: 5.264

3.  Intracanal medicaments: evaluation of the antibacterial effects of chlorhexidine, metronidazole, and calcium hydroxide associated with three vehicles.

Authors:  J F Siqueira; M de Uzeda
Journal:  J Endod       Date:  1997-03       Impact factor: 4.171

Review 4.  The fate and the role of bacteria left in root dentinal tubules.

Authors:  L B Peters; P R Wesselink; W R Moorer
Journal:  Int Endod J       Date:  1995-03       Impact factor: 5.264

5.  Bacteriologic evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy.

Authors:  A Byström; G Sundqvist
Journal:  Scand J Dent Res       Date:  1981-08

Review 6.  Chlorhexidine in dental practice.

Authors:  P Gjermo
Journal:  J Clin Periodontol       Date:  1974       Impact factor: 8.728

Review 7.  Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment.

Authors:  Charles H Stuart; Scott A Schwartz; Thomas J Beeson; Christopher B Owatz
Journal:  J Endod       Date:  2006-02       Impact factor: 4.171

8.  In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses.

Authors:  Y Roche; R N Yoshimori
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

9.  Antimicrobial efficacy of a polymeric chlorhexidine release device using in vitro model of Enterococcus faecalis dentinal tubule infection.

Authors:  Yoon Lee; Seung Hyun Han; Sang-Hee Hong; Jin-Kyung Lee; Hye Ji; Kee-Yeon Kum
Journal:  J Endod       Date:  2008-05-22       Impact factor: 4.171

10.  Disinfection of dentinal tubules with 2% chlorhexidine, 2% metronidazole, bioactive glass when compared with calcium hydroxide as intracanal medicaments.

Authors:  Jogikalmat Krithikadatta; Rajamani Indira; Alfred Leo Dorothykalyani
Journal:  J Endod       Date:  2007-12       Impact factor: 4.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.